Your skin phenotype, a joint screen, and proven control
Stem cell therapy for psoriasis in Istanbul, Turkey
Our Istanbul dermatology team confirms your psoriasis severity, screens for joint involvement, and keeps established therapy at the center of your plan.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Direct answer
What the current evidence says
We don't offer stem cell or exosome therapy as a psoriasis cure, because no generic MSC product has proven reliable plaque clearance or replacement of modern biologic treatment. What we do offer is a dermatology-led evaluation of your severity, joint symptoms, and prior therapy, with proven topical, systemic, and biologic options at the center of your plan. Request your free medical evaluation and we'll be candid about where the evidence stands.
Clinical map
Start with the diagnosis, stage, and treatment context
Psoriasis has highly effective guideline-based options, and we never let an experimental claim delay your skin and joint control.
Established care comes first
- Topical and light therapy: We use topical corticosteroids, vitamin D analogues, and phototherapy when appropriate.
- Systemic treatment: We help select conventional systemic medicines, small molecules, or biologics according to your severity and preference.
- Joint protection: We refer suspected psoriatic arthritis promptly, because untreated joint disease can cause lasting damage.
- 01
Skin burden
We measure body surface area, location, symptoms, and impact on sleep, work, and mood.
- 02
Joint and enthesis screen
Inflammatory pain, swelling, and nail disease can signal psoriatic arthritis, and we screen for it proactively.
- 03
Comorbidity
Cardiometabolic disease, smoking, and mood all factor into your treatment plan.
Evidence position
What is known, what is investigational, and what is not demonstrated
Established control, no proven cell shortcut
Psoriasis involves IL-23, Th17, and IL-17 immune pathways, but a plausible mechanism is not proof a cell product improves your outcome, and we say so.
We won't oversell IV immune modulation
Nail, scalp, and joint involvement can change urgency and treatment choice, which we screen for at every visit.
Topical exosome claims need real evidence
Results vary between patients and stem cell therapy is not a guaranteed cure — case reports don't support claims of PASI 75 or biologic-free control.
Product and route
A mechanism is not a clinical outcome
- 01
We won't oversell IV immune modulation
An infusion cannot be assumed to safely target plaques or joints, and we explain that clearly before any decision.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
Topical exosome claims need real evidence
Before-and-after photos don't establish PASI response or durable control, and we hold every claim to that standard.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 European psoriasis treatment guideline
Open source- Product
- Established topical, phototherapy, conventional systemic, targeted, and biologic options
- Route
- Treatment-specific
- Design
- Evidence and consensus-based clinical guideline
- Finding
- The guideline provides evidence-based treatment pathways and does not establish MSC or exosome therapy for psoriasis.
- Limitation
- Cell research remains insufficient for routine clinical efficacy claims.
Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
PASI and body surface area
- 02
Physician Global Assessment
- 03
Dermatology Life Quality Index
- 04
Nail and scalp outcomes
- 05
Joint symptoms and treatment side effects
Specialist review
What a complete Istanbul review needs
Our Istanbul dermatology team confirms your psoriasis severity, screens for joint involvement, and keeps established therapy at the center of your plan.
Records and baseline
- Dermatologist-confirmed phenotype and severity
- Standardized skin, scalp, and nail assessment
- Psoriatic arthritis screen and rheumatology review when indicated
- Prior topicals, phototherapy, systemic medicines, and response
- Infection, liver, kidney, and cardiometabolic review
Safety and planning checks
- Erythroderma, generalized pustular disease, or rapidly worsening skin gets urgent hospital assessment.
- We never ask you to stop an effective biologic or systemic medicine without your treating dermatologist.
- Your Istanbul plan identifies a measurable skin or joint endpoint and is honest about where established options remain best.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- Erythroderma, generalized pustular disease, or rapidly worsening skin gets urgent hospital assessment.
- We never ask you to stop an effective biologic or systemic medicine without your treating dermatologist.
- Your Istanbul plan identifies a measurable skin or joint endpoint and is honest about where established options remain best.
Questions the plan must answer
- 01
We won't oversell IV immune modulation: An infusion cannot be assumed to safely target plaques or joints, and we explain that clearly before any decision.
- 02
Topical exosome claims need real evidence: Before-and-after photos don't establish PASI response or durable control, and we hold every claim to that standard.
Primary reading
Guidelines, trials, and regulatory context
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.